BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anthony C, Imran M, Pouliopoulos J, Emmanuel S, Iliff JW, Moffat KJ, Ross J, Graham RM, Kotlyar E, Muthiah K, Keogh AM, Hayward CS, Macdonald P, Jabbour A. Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study). JACC Heart Fail 2021;9:301-13. [PMID: 33795116 DOI: 10.1016/j.jchf.2021.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Elezaby A, Dexheimer R, Sallam K. Cardiovascular effects of immunosuppression agents. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.981838] [Reference Citation Analysis]
2 Choi HI, Kang DY, Kim MS, Lee SE, Ahn JM, Lee JY, Kim YH, Park DW, Jung SH, Kim JJ. Long-term efficacy of everolimus as de novo immunosuppressant on the cardiac allograft vasculopathy in heart transplant recipients. Atherosclerosis 2022;357:1-8. [PMID: 35981436 DOI: 10.1016/j.atherosclerosis.2022.08.005] [Reference Citation Analysis]
3 David-Neto E, Filho MPM, de Sá ÍJAS, Agena F, de Andrade JL, de Paula FJ. The impact of mTOR inhibitors in the regression of left ventricular hypertrophy in elderly kidney transplant recipients. Clin Transplant 2022;:e14742. [PMID: 35678134 DOI: 10.1111/ctr.14742] [Reference Citation Analysis]
4 Gilliland S, Alber S, Tregear H, Hennigan A, Weitzel N. Year in Review 2021: Noteworthy Literature in Cardiothoracic Critical Care. Semin Cardiothorac Vasc Anesth 2022;:10892532221100663. [PMID: 35533191 DOI: 10.1177/10892532221100663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 de la Fuente-Mancera JC, Forado-Bentar I, Farrero M. Management of long-term cardiovascular risk factors post organ transplant. Curr Opin Organ Transplant 2022;27:29-35. [PMID: 34939962 DOI: 10.1097/MOT.0000000000000950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Meucci MC, Reinders MEJ, Groeneweg KE, Bezstarosti S, Ajmone Marsan N, Bax JJ, De Fijter JW, Delgado V. Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study. J Am Heart Assoc 2021;10:e023300. [PMID: 34913362 DOI: 10.1161/JAHA.121.023300] [Reference Citation Analysis]